{"gene":"DGKD","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1996,"finding":"DGKδ was cloned and identified as a diacylglycerol kinase with lipid kinase activity (phosphorylates DAG to produce phosphatidic acid). It contains a pleckstrin homology (PH) domain, two cysteine-rich zinc finger-like C1 structures, a C-terminal SAM-like domain, and a long Glu/Ser-rich insertion. DGK activity was detected in the particulate fraction of COS-7 cells expressing transfected DGKδ cDNA. The enzyme activity was independent of phosphatidylserine (unlike previously cloned DGKs alpha, beta, gamma).","method":"cDNA cloning, heterologous expression in COS-7 cells, in vitro DGK activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct enzymatic activity assay in cells, structural characterization, foundational cloning paper replicated by many subsequent studies","pmids":["8626538"],"is_preprint":false},{"year":2002,"finding":"Alternative splicing of the DGKD gene generates two isoforms: DGKδ1 (130 kDa) and DGKδ2 (135 kDa, with 52 N-terminal residues extended). DGKδ1 translocates from cytoplasm to plasma membrane via its PH domain in response to phorbol ester stimulation, whereas DGKδ2 remains cytoplasmic because the delta2-specific N-terminal sequence blocks phorbol ester-dependent translocation. The two isoforms form homo- and hetero-oligomers as shown by co-immunoprecipitation of differently tagged proteins.","method":"Alternative splicing analysis, phorbol ester stimulation assays, subcellular localization by imaging, co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, subcellular localization with functional consequence (translocation), multiple orthogonal methods in one rigorous study","pmids":["12200442"],"is_preprint":false},{"year":2002,"finding":"DGKδ suppresses anterograde ER-to-Golgi transport via its SAM domain (acting as ER-targeting motif) and PH domain. Low-level expression redistributed Golgi membrane markers to the ER, delayed VSV-G protein transport, and abolished COPII-coated structure formation (labeled with Sec13p) without affecting COPI structures. Kinase-dead DGKδ mutants were equally effective, indicating the catalytic activity is not required for this function. Both SAM and PH domains were required.","method":"Expression of wild-type and kinase-dead DGKδ in NIH3T3 cells, VSV-G transport assay, BFA washout assay, immunofluorescence, domain deletion analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — kinase-dead mutagenesis, domain deletion analysis, multiple orthogonal functional assays in a single rigorous study","pmids":["11809841"],"is_preprint":false},{"year":2002,"finding":"DGKδ forms homo-oligomeric structures via its C-terminal SAM domain, forming dimers and tetramers. Phorbol ester stimulation induces PKC-dependent phosphorylation of DGKδ, dissociation of oligomers, and translocation from cytoplasmic vesicles to the plasma membrane. DGKδ mutants lacking self-association localized constitutively at the plasma membrane even without phorbol ester. Staurosporine (PKC inhibitor) blocked all phorbol ester effects.","method":"Yeast two-hybrid, bacterial expression of SAM domain-MBP fusion, gel filtration, co-immunoprecipitation, phorbol ester stimulation, PKC inhibitor (staurosporine) treatment, subcellular localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reconstitution of SAM domain oligomers in vitro, co-IP in intact cells, mutagenesis, multiple orthogonal methods","pmids":["12084710"],"is_preprint":false},{"year":2006,"finding":"DGKδ deficiency in mice causes DAG accumulation, increased PKC-dependent threonine phosphorylation of EGFR, and reduced EGFR protein expression and activity. DGKδ-deficient pups showed open eyelids at birth and died shortly after birth, phenocopying EGFR knockout mice. Increased PKC autophosphorylation and enhanced phosphorylation of other PKC substrates was observed in DGKδ knockout cells, indicating DGKδ regulates EGFR by modulating PKC signaling.","method":"Gene knockout in mice, biochemical measurement of DAG, EGFR phosphorylation, PKC autophosphorylation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with defined molecular phenotype, multiple biochemical readouts, epistasis with PKC-EGFR pathway","pmids":["17021016"],"is_preprint":false},{"year":2007,"finding":"DGKδ subcellular localization is regulated by glucose: in L6 myotubes overexpressing human insulin receptors, 25 mM glucose for 5 min transiently redistributed DGKδ (but not DGKα) from cytosol to plasma membrane fraction, reducing intracellular DAG and PKCα activity, and transactivating insulin receptor signaling and GLUT4 translocation. Antisense silencing of DGKδ (but not DGKα) prevented the effect of high glucose on PKCα activity, insulin receptor signaling, and glucose uptake.","method":"Antisense knockdown, subcellular fractionation, DGK activity assay, PKCα activity assay, insulin receptor signaling assay, GLUT4 translocation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-specific knockdown with defined signaling readouts, subcellular fractionation, multiple orthogonal methods","pmids":["17675299"],"is_preprint":false},{"year":2008,"finding":"DGKδ (specifically DGKδ2) regulates clathrin-dependent endocytosis by binding to the AP2α subunit of the AP-2 complex via DXF-type motifs (F369DTFRIL and D746PF in the catalytic domain). DGKδ2 colocalized with clathrin-coated pits. Mutants lacking AP2α binding ability or kinase-negative mutants failed to rescue transferrin uptake inhibited by DGKδ siRNA knockdown, demonstrating that both the AP2α interaction and kinase activity are required for the endocytic function.","method":"Co-immunoprecipitation, siRNA knockdown, domain mapping, kinase-dead mutagenesis, transferrin and EGF uptake assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, mutagenesis of binding motifs, kinase-dead mutant, functional rescue assay — multiple orthogonal methods","pmids":["17880279"],"is_preprint":false},{"year":2008,"finding":"Reduced DGKδ expression and DGK activity were found in skeletal muscle from type 2 diabetic patients and diabetic animals. DGKδ haploinsufficiency in mice increased diacylglycerol content, reduced peripheral insulin sensitivity, insulin signaling, and glucose transport, and led to age-dependent obesity. Metabolic flexibility (transition between lipid and carbohydrate utilization) was impaired in DGKδ haploinsufficient mice. Correction of glycemia in diabetic animals restored DGKδ protein and DGK kinase activity.","method":"Human skeletal muscle biopsies, DGKδ haploinsufficient mouse model, DGK kinase activity assay, glucose transport assay, metabolic flexibility measurements","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — combined human and mouse genetic evidence, multiple metabolic readouts, kinase activity measurements; highly cited foundational study","pmids":["18267070"],"is_preprint":false},{"year":2009,"finding":"DGKδ associates with RACK1 (receptor for activated C kinase 1) via WD40 repeats 5-7 of RACK1 interacting with aa 896-1097 of DGKδ. The interaction was selective for DGKδ over type I DGKs and was dynamically regulated by phorbol ester. DGKδ appeared to recruit RACK1 to clathrin-coated vesicles and co-localized with RACK1.","method":"Yeast two-hybrid screening, co-immunoprecipitation in COS-7 cells, subcellular localization, phorbol ester stimulation","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP with domain mapping, colocalization, single lab with two orthogonal approaches","pmids":["19416640"],"is_preprint":false},{"year":2010,"finding":"DGKδ and PKCα regulate EGFR abundance through the deubiquitinase USP8. In DGKδ-deficient cells, ubiquitination of EGFR was enhanced, reducing steady-state EGFR levels and promoting ligand-induced EGFR degradation. This was not due to changes in the ubiquitinating apparatus but to reduced expression of USP8. PKCα, excessively active in DGKδ-deficient cells, inhibited Akt, which normally stabilizes USP8. Depletion of PKCα rescued USP8 levels and normalized EGFR degradation.","method":"DGKδ knockout cells, ubiquitination assay, USP8 expression analysis, PKCα depletion, Akt pathway analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO, epistasis analysis through PKCα-Akt-USP8 pathway, multiple biochemical readouts, mechanistic rescue experiments","pmids":["20064931"],"is_preprint":false},{"year":2010,"finding":"The SAM domain of DGKδ forms helical polymers that are stabilized by zinc binding. Zinc drives organization of DGKδ-SAM into large sheets of polymers. A SAM domain mutant refractory to zinc binding diminishes cytoplasmic puncta formation, shows partially impaired regulation of transport to the plasma membrane, and lacks the ability to inhibit CopII-coated vesicle formation.","method":"Biochemical analysis of SAM domain, zinc binding studies, mutagenesis, cell-based localization assay, CopII vesicle formation assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro reconstitution of SAM polymer assembly, zinc-binding mutagenesis linked to functional cellular phenotypes, single lab with multiple orthogonal methods","pmids":["20857926"],"is_preprint":false},{"year":2012,"finding":"DGKδ deficiency reduces Akt phosphorylation downstream of three receptor tyrosine kinases. Mechanistically, PKCα (excessively active in DGKδ-deficient cells) promotes dephosphorylation of Akt through PHLPP2 (not PHLPP1). β-arrestin 1 acts as a scaffold for PHLPP2 and Akt1, providing mechanism specificity. Depletion of either PKCα or PHLPP2 rescued Akt phosphorylation in DGKδ-deficient cells. DGKδ deficiency reduced cell proliferation and migration and enhanced apoptosis.","method":"DGKδ-deficient cells, Akt phosphorylation assays, PKCα and PHLPP1/2 depletion, siRNA knockdown, cell proliferation and migration assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic depletion epistasis (PKCα vs PHLPP2 vs PHLPP1), isoform-specific rescue, multiple orthogonal functional readouts","pmids":["23184957"],"is_preprint":false},{"year":2012,"finding":"DGKδ1 (but not DGKδ2 or type II DGKη1/2) specifically translocates from cytoplasm to plasma membrane within 5 min in response to high glucose in HEK293 and C2C12 cells. This translocation is regulated via the PI3-kinase pathway (blocked by LY294002 and GDC-0941). The PH and C1 domains are required for plasma membrane translocation, while the SAM domain negatively regulates it.","method":"Subcellular localization imaging, PI3-kinase inhibitors, domain deletion mutants, high glucose stimulation","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-selective translocation, pharmacological inhibition, domain mutagenesis, multiple cell lines","pmids":["22974639"],"is_preprint":false},{"year":2014,"finding":"DGKδ2 preferentially phosphorylates palmitic acid (16:0)-containing diacylglycerol species (generating 30:0-, 32:0-, 34:0-PA and moderately 30:1-, 32:1-, 34:1-PA) in response to high glucose in C2C12 myoblasts. These DG species are supplied from the phosphatidylcholine-specific phospholipase C (PC-PLC) pathway (blocked by D609 inhibitor), not from the phosphatidylinositol turnover pathway. PC-PLC was co-immunoprecipitated with DGKδ2, indicating a physical interaction.","method":"LC/MS for PA species analysis, DGKδ-specific siRNA knockdown, DGKδ2 overexpression, PC-PLC inhibitor D609, co-immunoprecipitation, MS/MS analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — quantitative LC/MS substrate specificity, siRNA KD + overexpression, co-IP, pharmacological pathway blockade — multiple orthogonal methods","pmids":["25112873"],"is_preprint":false},{"year":2015,"finding":"DGKδ deficiency impairs AMPK activation and signaling in isolated skeletal muscle, with concomitant impaired lipid oxidation and elevated incorporation of free fatty acids into triglycerides. DGKδ haploinsufficient mice showed reduced voluntary running activity and impaired work performance (altered force production and relaxation dynamics) during repeated contractions.","method":"DGKδ haploinsufficient mice, AMPK signaling assays, lipid oxidation measurements, voluntary running wheel, ex vivo muscle contraction force measurements","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mouse model, multiple biochemical and physiological readouts, single lab","pmids":["26530149"],"is_preprint":false},{"year":2016,"finding":"Brain-specific DGKδ-knockout mice display OCD-like behaviors (compulsive checking, increased marble burying) alleviated by fluoxetine (SSRI). DGKδ deficiency increased the number of long axons/neurites in primary cortical neurons and knockdown neuroblastoma cells, whereas DGKδ overexpression decreased long axon/neurite number, indicating DGKδ regulates axon/neurite outgrowth.","method":"Brain-specific conditional DGKδ knockout mice, novel object recognition test, marble burying test, fluoxetine treatment, neurite outgrowth measurements in primary neurons and Neuro-2a cells","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with behavioral and cellular phenotypes, pharmacological rescue, gain-of-function overexpression corroboration","pmids":["27423518"],"is_preprint":false},{"year":2017,"finding":"DGKδ is required for ER exit site function: it triggers the release of IFT88-containing vesicles from ER exit sites (ERES) for transport to the primary cilium. IFT88 interacts with DGKδ, and IFT88 associates with COPII-coated vesicles at ERES. DGKδ is required for supporting Sonic hedgehog (Shh) signaling both in vitro and in vivo.","method":"RNAi silencing and gene knockout, IFT88-DGKδ co-immunoprecipitation, COPII vesicle association assay, Shh signaling assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi + KO with cellular and in vivo Shh signaling phenotypes, co-IP for IFT88 interaction, single lab","pmids":["28706295"],"is_preprint":false},{"year":2018,"finding":"DGKδ deficiency in the brain increases serotonin transporter (SERT) protein levels in the cerebral cortex, decreases tryptophan hydroxylase-2 expression, increases monoamine oxidase-A expression, and reduces serotonin (5-HT) levels. DGKδ interacted and co-localized with SERT in cortical neurons.","method":"Brain-specific DGKδ knockout mice, Western blot for SERT/TPH2/MAO-A, HPLC for 5-HT quantification, co-immunoprecipitation, colocalization imaging","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO mouse with multiple serotonergic readouts, co-IP for SERT interaction, single lab","pmids":["29486157"],"is_preprint":false},{"year":2018,"finding":"DGKδ controls down-regulation of cyclin D1 during C2C12 myogenic differentiation. DGKδ siRNA knockdown increased cyclin D1 and phospho-conventional/novel PKC (cnPKC) levels, and decreased myogenin expression and myosin heavy chain-positive cell number. These results indicate DGKδ regulates early myoblast differentiation by attenuating PKC signaling to control cyclin D1 down-regulation.","method":"siRNA knockdown, Western blot for cyclin D1/myogenin/myosin heavy chain/phospho-PKC, BrdU incorporation assay","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD with defined molecular and cellular phenotypes, mechanistic link to PKC signaling, single lab","pmids":["29859210"],"is_preprint":false},{"year":2019,"finding":"DGKδ induces ubiquitination and proteasomal degradation of serotonin transporter (SERT) in a catalytic activity-dependent manner. Mechanistically, DGKδ interacts with MAGE-D1 adaptor protein and Praja-1 E3 ubiquitin-protein ligase, and enhances SERT ubiquitination through Praja-1. The catalytic subdomain-a and coiled-coil structure-containing region of DGKδ interacts with the C-terminal cytoplasmic region of SERT. Proteasome inhibitor MG-132 blocked DGKδ-dependent SERT degradation.","method":"Co-immunoprecipitation (DGKδ-SERT, DGKδ-MAGE-D1, DGKδ-Praja-1), domain mapping, catalytic mutants, ubiquitination assay, proteasome inhibitor treatment","journal":"Biochimica et biophysica acta. Molecular and cell biology of lipids","confidence":"High","confidence_rationale":"Tier 2 / Strong — catalytic activity-dependent mechanism, multiple co-IP interactions mapped, ubiquitination assay, pharmacological rescue, multiple orthogonal methods","pmids":["31891772"],"is_preprint":false},{"year":2019,"finding":"DGKD knockdown impairs calcium-sensing receptor (CaSR) signal transduction in vitro, and this impairment is rectified by the calcimimetic cinacalcet. DGKD-associated genetic loci in kidney stone patients correlate with urinary calcium excretion, placing DGKD in the CaSR signaling pathway.","method":"siRNA knockdown of DGKD in CaSR-expressing cells, CaSR signaling assay, cinacalcet rescue","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with defined signaling readout and pharmacological rescue, supported by human genetic correlation; single lab in vitro validation","pmids":["31729369"],"is_preprint":false},{"year":2020,"finding":"1-stearoyl-2-docosahexaenoyl (18:0/22:6)-phosphatidic acid (PA), selectively generated by DGKδ from 18:0/22:6-DG, specifically binds to and enhances the activity of Praja-1 E3 ubiquitin ligase. In DGKδ-knockout mouse brain, 18:0/22:6-PA was decreased while 18:0/22:6-DG accumulated, confirming DGKδ selectively phosphorylates this DG species. Thus DGKδ generates a specific PA species that activates its downstream effector Praja-1 to degrade SERT.","method":"DGKδ-knockout mouse brain lipidomics (LC/MS), PA-Praja-1 binding assay, Praja-1 activity assay","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — KO mouse lipidomics identifying substrate specificity, in vitro protein-lipid binding and activity assay, mechanistic chain from DGKδ to PA species to Praja-1 activation","pmids":["32134507"],"is_preprint":false},{"year":2020,"finding":"DGKδ interacts with sphingomyelin synthase-related protein (SMSr) through their respective SAM domains (SMSr-SAMD co-immunoprecipitates with DGKδ-SAMD; full-length interactions confirmed). SMSr overexpression significantly enhanced production of 16:0- or 16:1-containing PA species in DGKδ-overexpressing COS-7 cells. SMSr also enhanced DGKδ activity via their SAMDs in vitro, establishing SMSr as an upstream DG-providing enzyme for DGKδ.","method":"Co-immunoprecipitation (SAMD fragments and full-length), LC-MS/MS for PA species, in vitro DGK activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — SAM domain interaction mapped by co-IP, in vitro DGK activity assay, LC-MS/MS lipidomics — multiple orthogonal methods","pmids":["31980461"],"is_preprint":false},{"year":2021,"finding":"β-cell-specific DGKδ knockout mice showed lower blood glucose, higher plasma insulin, better glucose tolerance, increased small islets and Ki-67-positive islet cells, and elevated cyclin B1 expression. DGKδ knockdown in MIN6 β-cells increased BrdU incorporation and cyclin B1 expression. Streptozotocin-induced hyperglycemia and β-cell loss were alleviated in βDGKδ KO mice. DGKδ expression was detected in the nucleus of β-cells, establishing DGKδ as a suppressor of β-cell proliferation.","method":"β-cell-specific conditional DGKδ KO mice, Ki-67/cyclin B1 immunostaining, BrdU incorporation assay, streptozotocin model","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific KO, multiple proliferation readouts, KD confirmation in cell line, in vivo disease model rescue","pmids":["33774855"],"is_preprint":false},{"year":2024,"finding":"USP11 (ubiquitin-specific peptidase 11) specifically interacts with DGKδ protein complex and deubiquitinates DGKδ to stabilize it. The catalytic domain 1 region of USP11 and the C1 domains plus catalytic subdomain-a of DGKδ mediate their association. Inhibition of USP11 (by mitoxantrone or siRNA) markedly decreased DGKδ protein levels and increased DGKδ ubiquitination, impairing cellular glucose uptake.","method":"DGKδ-interactome analysis, co-immunoprecipitation, domain mapping, USP11 inhibitor (mitoxantrone), siRNA knockdown, ubiquitination assay, glucose uptake assay","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — interactome-based discovery, domain mapping, pharmacological + genetic inhibition, ubiquitination assay + rescue, functional glucose uptake readout","pmids":["39603461"],"is_preprint":false},{"year":2024,"finding":"DGKδ is required for skeletal muscle development and regeneration. Myf5-promoter-driven conditional DGKδ knockout mice showed reduced body weight and skeletal muscle mass with reduced myofiber thickness. After cardiotoxin-induced muscle injury, DGKδ expression was highly upregulated, and DGKδ-deficient muscles showed reduced myofiber thickness, decreased embryonic myosin heavy chain and myogenin expression, and fewer newly formed centronucleated myofibers. DGKδ was expressed in myogenin-positive satellite cells around injured myofibers.","method":"Conditional DGKδ knockout (Myf5-Cre), cardiotoxin injury model, immunohistochemistry for muscle markers, Western blot","journal":"FASEB bioAdvances","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO in two contexts (development and regeneration), multiple molecular markers, localization to satellite cells, single lab but comprehensive evidence","pmids":["39781426"],"is_preprint":false},{"year":2025,"finding":"PHOSPHO1 (a cytosolic phosphatase) exhibits D609-sensitive PC-PLC and PE-PLC activities, generating saturated and/or monounsaturated fatty acid-containing DG species. DGKδ cosedimented and colocalized with PHOSPHO1, identifying PHOSPHO1 as a candidate upstream DG-supplying enzyme for DGKδ in a PI-turnover-independent pathway.","method":"In vitro phospholipase activity assay with purified PHOSPHO1, D609 inhibitor, PHOSPHO1 overexpression with DG quantification, co-sedimentation and colocalization assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro enzymatic activity assay, cellular DG quantification, colocalization/cosedimentation for interaction; single lab, single study","pmids":["39992810"],"is_preprint":false},{"year":2025,"finding":"Reduced DGKδ expression and DGKD missense variants (identified via GWAS/Mendelian randomization) impaired CaSR signal transduction in vitro. This impairment was ameliorated by cinacalcet, a positive CaSR allosteric modulator. Drug target Mendelian randomization indicated reducing serum calcium via DGKD may reduce kidney stone disease relative risk by up to 90%.","method":"In vitro CaSR signaling assay with DGKD knockdown and missense variants, cinacalcet rescue, Mendelian randomization","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — variant-specific loss-of-function with defined signaling readout and pharmacological rescue, supported by GWAS colocalization; single lab in vitro validation","pmids":["40372791"],"is_preprint":false}],"current_model":"DGKδ is a lipid kinase that phosphorylates diacylglycerol (DAG) to produce phosphatidic acid (PA), preferentially utilizing saturated/monounsaturated FA-containing DG species (via PC-PLC/SMSr/PHOSPHO1 pathways) and 18:0/22:6-DG (for brain SERT regulation); it is regulated by PKC-dependent oligomerization/translocation via its SAM and PH domains, stabilized by USP11-mediated deubiquitination, and acts in multiple signaling nodes including terminating PKC-EGFR signaling, modulating CaSR signal transduction, promoting clathrin-dependent endocytosis through AP2α binding, triggering ER-to-Golgi/primary cilia trafficking, suppressing β-cell proliferation, and generating specific PA species (notably 18:0/22:6-PA) that activate Praja-1 E3 ligase to degrade the serotonin transporter."},"narrative":{"mechanistic_narrative":"DGKD encodes diacylglycerol kinase δ (DGKδ), a lipid kinase that phosphorylates diacylglycerol (DAG) to phosphatidic acid (PA) and thereby attenuates DAG-driven protein kinase C (PKC) signaling across metabolic, proliferative, neuronal, and trafficking contexts [PMID:8626538, PMID:17021016]. The protein is built from a PH domain, two C1 zinc fingers, and a C-terminal SAM domain, and is expressed as two splice isoforms (DGKδ1 and DGKδ2) that differ in their N-terminus and in their capacity to translocate to the plasma membrane [PMID:12200442]. SAM-domain–mediated, zinc-stabilized homo-oligomerization holds DGKδ in cytoplasmic vesicles; PKC-dependent phosphorylation downstream of phorbol ester or high glucose dissociates the oligomers and drives PH/C1-dependent translocation to the plasma membrane, where DGKδ consumes DAG [PMID:12084710, PMID:20857926, PMID:22974639]. A central physiological output of this circuit is metabolic control: glucose-stimulated DGKδ relocalization lowers DAG and PKCα activity to enable insulin receptor signaling and GLUT4-mediated glucose uptake, and DGKδ deficiency in muscle causes DAG accumulation, insulin resistance, impaired AMPK and lipid oxidation, and obesity — a state mirrored in human diabetic skeletal muscle [PMID:17675299, PMID:18267070, PMID:26530149]. DGKδ obtains its DAG substrate from a phosphatidylinositol-independent route, partnering with the DAG-supplying enzymes SMSr, PC-PLC, and PHOSPHO1 to generate saturated/monounsaturated PA species [PMID:25112873, PMID:31980461, PMID:39992810]. Through its PKC-modulating activity DGKδ also stabilizes EGFR by preserving USP8 and limiting EGFR ubiquitination, and supports Akt signaling by restraining PKCα-driven, β-arrestin-1/PHLPP2-mediated Akt dephosphorylation, controlling proliferation, migration, and survival [PMID:17021016, PMID:20064931, PMID:23184957]. Independently of its kinase activity, the SAM and PH domains target DGKδ to ER exit sites, where it regulates COPII-dependent ER-to-Golgi transport and releases IFT88-containing vesicles for primary cilium delivery to support Sonic hedgehog signaling; the kinase activity together with AP2α binding drives clathrin-dependent endocytosis [PMID:11809841, PMID:17880279, PMID:28706295]. In the brain, DGKδ generates 18:0/22:6-PA that binds and activates the Praja-1 E3 ligase (via the MAGE-D1 adaptor) to ubiquitinate and degrade the serotonin transporter, and its loss produces OCD-like behavior corrected by SSRI [PMID:27423518, PMID:31891772, PMID:32134507]. DGKδ further suppresses β-cell proliferation, is required for skeletal muscle development and regeneration, and is stabilized by USP11-mediated deubiquitination [PMID:33774855, PMID:39603461, PMID:39781426]. Loss of DGKD function impairs calcium-sensing receptor (CaSR) signaling, linking DGKD variants to urinary calcium handling and kidney stone disease, with rescue by the calcimimetic cinacalcet [PMID:31729369, PMID:40372791].","teleology":[{"year":1996,"claim":"Established DGKδ as a distinct DAG kinase, defining the catalytic activity and domain architecture that underlie all later mechanistic work.","evidence":"cDNA cloning and in vitro DGK activity assay of transfected enzyme in COS-7 cells","pmids":["8626538"],"confidence":"High","gaps":["No physiological substrate or DAG species defined","No cellular pathway context"]},{"year":2002,"claim":"Resolved how DGKδ is held inactive and switched on, showing SAM-domain oligomerization and PKC-dependent phosphorylation gate PH-domain translocation to the plasma membrane, and that splice isoforms differ in this control.","evidence":"Alternative splicing analysis, phorbol ester stimulation, yeast two-hybrid, gel filtration, co-IP and localization in cells","pmids":["12200442","12084710"],"confidence":"High","gaps":["PKC phosphorylation site not mapped","Physiological trigger beyond phorbol ester unknown at this stage"]},{"year":2002,"claim":"Revealed a kinase-independent trafficking role, showing the SAM and PH domains target DGKδ to the ER and suppress COPII-dependent ER-to-Golgi transport.","evidence":"Wild-type and kinase-dead expression in NIH3T3 cells with VSV-G transport, BFA washout, and domain deletion assays","pmids":["11809841"],"confidence":"High","gaps":["Cargo selectivity not defined","Mechanism of COPII inhibition unresolved"]},{"year":2006,"claim":"Defined the core physiological logic — DGKδ degrades DAG to limit PKC, and its loss deranges PKC-EGFR signaling — with a lethal eyelid-open phenotype phenocopying EGFR knockout.","evidence":"Mouse gene knockout with DAG, EGFR phosphorylation, and PKC autophosphorylation measurements","pmids":["17021016"],"confidence":"High","gaps":["Tissue-specific contributions not separated","Downstream effectors of altered PKC not enumerated"]},{"year":2007,"claim":"Connected DGKδ to glucose homeostasis, showing glucose-triggered DGKδ membrane translocation lowers DAG/PKCα to enable insulin receptor signaling and GLUT4 translocation.","evidence":"Antisense knockdown, subcellular fractionation, and signaling/glucose-uptake assays in L6 myotubes","pmids":["17675299"],"confidence":"High","gaps":["Signal coupling glucose to translocation not defined here","Isoform responsible not yet pinned down"]},{"year":2008,"claim":"Linked DGKδ to human type 2 diabetes, demonstrating reduced muscle DGKδ in patients and that haploinsufficiency causes DAG accumulation, insulin resistance, and obesity.","evidence":"Human muscle biopsies and DGKδ haploinsufficient mice with kinase activity, glucose transport, and metabolic flexibility readouts","pmids":["18267070"],"confidence":"High","gaps":["Causality vs consequence of reduced expression in patients not fully resolved","Therapeutic targeting not tested"]},{"year":2008,"claim":"Identified a clathrin-endocytosis role requiring both AP2α binding via DXF motifs and kinase activity, mediated by the DGKδ2 isoform.","evidence":"Co-IP, domain/motif mapping, kinase-dead mutagenesis, and transferrin/EGF uptake rescue after siRNA knockdown","pmids":["17880279"],"confidence":"High","gaps":["Local PA pool driving endocytosis not directly measured","Cargo range beyond transferrin/EGF unknown"]},{"year":2009,"claim":"Added RACK1 as a phorbol-ester-regulated DGKδ partner recruited to clathrin-coated vesicles, integrating DGKδ with PKC scaffolding.","evidence":"Yeast two-hybrid, co-IP with domain mapping, and colocalization in COS-7 cells","pmids":["19416640"],"confidence":"Medium","gaps":["Functional consequence of RACK1 recruitment not established","No reciprocal validation in physiological cells"]},{"year":2010,"claim":"Detailed how DGKδ controls EGFR abundance and Akt activity through PKCα, showing PKCα-driven loss of USP8 and PHLPP2/β-arrestin-1-mediated Akt dephosphorylation in DGKδ-deficient cells.","evidence":"DGKδ knockout cells with ubiquitination, USP8 expression, PKCα/PHLPP depletion, and Akt pathway analyses","pmids":["20064931","23184957"],"confidence":"High","gaps":["Direct PA targets within these pathways not identified","Tissue relevance of the PHLPP2 axis untested in vivo"]},{"year":2010,"claim":"Showed zinc binding drives DGKδ-SAM into helical polymers required for cytoplasmic puncta, membrane translocation control, and COPII inhibition, mechanistically grounding the oligomerization switch.","evidence":"In vitro SAM polymer/zinc-binding studies with mutagenesis linked to cellular localization and COPII assays","pmids":["20857926"],"confidence":"High","gaps":["Regulation of zinc-dependent assembly in vivo unknown","Structural model of the full polymer not resolved"]},{"year":2012,"claim":"Defined isoform-specific, PI3-kinase-dependent translocation, showing DGKδ1 responds to high glucose via PH/C1 domains while the SAM domain restrains translocation.","evidence":"Localization imaging with PI3K inhibitors and domain deletion mutants in HEK293/C2C12 cells","pmids":["22974639"],"confidence":"High","gaps":["Upstream sensor of glucose not identified","Link between PI3K and SAM-domain release unresolved"]},{"year":2014,"claim":"Established DGKδ substrate specificity and its DAG source, showing DGKδ2 phosphorylates 16:0-containing DAG supplied by PC-PLC, not PI turnover.","evidence":"LC/MS PA species analysis with siRNA/overexpression, PC-PLC inhibitor D609, and PC-PLC co-IP in C2C12 cells","pmids":["25112873"],"confidence":"High","gaps":["Identity of the PC-PLC enzyme not defined here","Functional consequence of specific PA species not yet assigned"]},{"year":2017,"claim":"Extended the trafficking role to ciliogenesis, showing DGKδ releases IFT88 vesicles from ER exit sites to support Sonic hedgehog signaling.","evidence":"RNAi/knockout, IFT88-DGKδ co-IP, COPII association, and Shh signaling assays in vitro and in vivo","pmids":["28706295"],"confidence":"Medium","gaps":["Whether kinase activity is required not established","Mechanism of IFT88 vesicle release unresolved"]},{"year":2018,"claim":"Uncovered a serotonergic function, showing brain DGKδ loss raises SERT and disrupts serotonin metabolism, producing OCD-like behavior rescued by SSRI, with DGKδ also restraining neurite outgrowth.","evidence":"Brain-specific conditional knockout with behavior, fluoxetine rescue, HPLC 5-HT, SERT co-IP, and neurite assays","pmids":["27423518","29486157"],"confidence":"Medium","gaps":["Mechanism of SERT regulation not yet defined at this stage","Cell types responsible for behavior unresolved"]},{"year":2019,"claim":"Resolved the SERT mechanism, showing kinase-activity-dependent DGKδ recruits MAGE-D1 and Praja-1 to ubiquitinate and degrade SERT.","evidence":"Co-IP of DGKδ with SERT/MAGE-D1/Praja-1, domain mapping, catalytic mutants, ubiquitination assay, and MG-132 rescue","pmids":["31891772"],"confidence":"High","gaps":["The PA species linking kinase activity to Praja-1 not yet identified here","Stoichiometry of the complex unknown"]},{"year":2019,"claim":"Placed DGKD in the CaSR signaling pathway, linking its loss-of-function to impaired CaSR signaling and urinary calcium handling in kidney stone patients.","evidence":"siRNA knockdown in CaSR-expressing cells with signaling assay, cinacalcet rescue, and genetic locus correlation","pmids":["31729369"],"confidence":"Medium","gaps":["Molecular mechanism coupling DGKδ to CaSR signaling not defined","In vivo calcium phenotype not directly tested"]},{"year":2020,"claim":"Closed the lipid-signaling loop for SERT, showing DGKδ selectively generates 18:0/22:6-PA that binds and activates Praja-1, and identifying SMSr as a SAM-domain partner supplying DAG.","evidence":"Knockout-brain lipidomics, PA-Praja-1 binding/activity assays, and SMSr-DGKδ SAM co-IP with LC-MS/MS and in vitro kinase assays","pmids":["32134507","31980461"],"confidence":"High","gaps":["How a single PA species achieves Praja-1 selectivity unresolved","Generality of SMSr supply across tissues untested"]},{"year":2021,"claim":"Defined DGKδ as a nuclear-localized suppressor of β-cell proliferation whose loss protects against streptozotocin-induced β-cell loss.","evidence":"β-cell-specific conditional knockout with Ki-67/cyclin B1/BrdU readouts and streptozotocin model","pmids":["33774855"],"confidence":"High","gaps":["Nuclear substrate/target of DGKδ in β-cells unknown","Relationship to PKC signaling in this context unresolved"]},{"year":2024,"claim":"Identified post-translational stabilization of DGKδ, showing USP11 deubiquitinates DGKδ and is required to maintain its levels and downstream glucose uptake.","evidence":"Interactome analysis, co-IP with domain mapping, USP11 inhibition (mitoxantrone/siRNA), ubiquitination and glucose-uptake assays","pmids":["39603461"],"confidence":"High","gaps":["E3 ligase ubiquitinating DGKδ not identified","Regulation of USP11-DGKδ engagement unknown"]},{"year":2024,"claim":"Established DGKδ as required for skeletal muscle development and injury-induced regeneration, with upregulation in satellite cells after injury.","evidence":"Myf5-Cre conditional knockout, cardiotoxin injury model, and muscle-marker immunohistochemistry/Western blot","pmids":["39781426"],"confidence":"High","gaps":["Molecular mechanism in satellite cell differentiation not defined","Lipid signaling basis of the regeneration defect unknown"]},{"year":2025,"claim":"Added PHOSPHO1 as a candidate PI-turnover-independent DAG supplier and strengthened the DGKD-CaSR-kidney stone link with variant-specific loss-of-function and Mendelian randomization.","evidence":"In vitro PHOSPHO1 phospholipase assays with D609 and DG quantification; CaSR signaling with DGKD variants, cinacalcet rescue, and Mendelian randomization","pmids":["39992810","40372791"],"confidence":"Medium","gaps":["Direct demonstration that PHOSPHO1 feeds DGKδ in vivo lacking","Causal mechanism of variants on CaSR signaling not fully defined"]},{"year":null,"claim":"How DGKδ's distinct PA species are spatially channeled to specific effectors (Praja-1, AP2α-coupled endocytosis, CaSR, nuclear β-cell targets) across tissues, and what unifies its kinase-dependent versus kinase-independent functions, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of full-length DGKδ in its membrane-engaged state","Effector selectivity for individual PA species mechanistically unexplained","E3 ligase opposing USP11 stabilization unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,13,21,22]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[6,19]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[21]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[6,19]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,3,12]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3,5,12]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,16]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[3,6,8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[23]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,5,11,20]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5,7,14]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,6,16]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[9,19,24]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[25,16]}],"complexes":["AP-2 clathrin adaptor complex"],"partners":["AP2A1","RACK1","SMSR/SAMD8","PHOSPHO1","IFT88","SLC6A4/SERT","PJA1/PRAJA-1","USP11"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16760","full_name":"Diacylglycerol kinase delta","aliases":["130 kDa diacylglycerol kinase","Diglyceride kinase delta","DGK-delta"],"length_aa":1214,"mass_kda":134.5,"function":"Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids (PubMed:12200442, PubMed:23949095). Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (Probable). By controlling the levels of diacylglycerol, regulates for instance the PKC and EGF receptor signaling pathways and plays a crucial role during development (By similarity). May also regulate clathrin-dependent endocytosis (PubMed:17880279)","subcellular_location":"Cell membrane; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q16760/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DGKD","classification":"Not Classified","n_dependent_lines":30,"n_total_lines":1208,"dependency_fraction":0.024834437086092714},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DGKD","total_profiled":1310},"omim":[{"mim_id":"609995","title":"MYOPIA 12, AUTOSOMAL DOMINANT; MYP12","url":"https://www.omim.org/entry/609995"},{"mim_id":"604071","title":"DIACYLGLYCEROL KINASE, ETA, 130-KD; DGKH","url":"https://www.omim.org/entry/604071"},{"mim_id":"601826","title":"DIACYLGLYCEROL KINASE, DELTA, 130-KD; DGKD","url":"https://www.omim.org/entry/601826"},{"mim_id":"300837","title":"DIACYLGLYCEROL KINASE, KAPPA, 142-KD; DGKK","url":"https://www.omim.org/entry/300837"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":29.7},{"tissue":"skeletal muscle","ntpm":26.7}],"url":"https://www.proteinatlas.org/search/DGKD"},"hgnc":{"alias_symbol":["KIAA0145","DGKdelta"],"prev_symbol":[]},"alphafold":{"accession":"Q16760","domains":[{"cath_id":"2.30.29.30","chopping":"46-156","consensus_level":"high","plddt":78.5996,"start":46,"end":156},{"cath_id":"2.60.200.40","chopping":"760-937","consensus_level":"medium","plddt":83.2815,"start":760,"end":937},{"cath_id":"1.20.120,1.20.1440","chopping":"974-1095","consensus_level":"high","plddt":81.0267,"start":974,"end":1095},{"cath_id":"1.10.150.50","chopping":"1143-1207","consensus_level":"high","plddt":90.3698,"start":1143,"end":1207},{"cath_id":"1.10.246","chopping":"477-524_534-557","consensus_level":"medium","plddt":74.865,"start":477,"end":557}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16760","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16760-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16760-F1-predicted_aligned_error_v6.png","plddt_mean":71.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DGKD","jax_strain_url":"https://www.jax.org/strain/search?query=DGKD"},"sequence":{"accession":"Q16760","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16760.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16760/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16760"}},"corpus_meta":[{"pmid":"18267070","id":"PMC_18267070","title":"Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18267070","citation_count":195,"is_preprint":false},{"pmid":"8626538","id":"PMC_8626538","title":"Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626538","citation_count":158,"is_preprint":false},{"pmid":"24068962","id":"PMC_24068962","title":"Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24068962","citation_count":158,"is_preprint":false},{"pmid":"31729369","id":"PMC_31729369","title":"Genetic variants of calcium and vitamin D metabolism in kidney stone disease.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31729369","citation_count":108,"is_preprint":false},{"pmid":"16210324","id":"PMC_16210324","title":"Identification and characterization of a novel human type II diacylglycerol kinase, DGK kappa.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16210324","citation_count":107,"is_preprint":false},{"pmid":"8702685","id":"PMC_8702685","title":"Cloning and characterization of a glucocorticoid-induced diacylglycerol kinase.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8702685","citation_count":91,"is_preprint":false},{"pmid":"12200442","id":"PMC_12200442","title":"Alternative splicing of the human diacylglycerol kinase delta gene generates two isoforms differing in their expression patterns and in regulatory functions.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12200442","citation_count":90,"is_preprint":false},{"pmid":"17021016","id":"PMC_17021016","title":"Diacylglycerol kinase delta regulates protein kinase C and epidermal growth factor receptor signaling.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17021016","citation_count":80,"is_preprint":false},{"pmid":"31848144","id":"PMC_31848144","title":"Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome highlight T cell-initiated autoimmunity.","date":"2019","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31848144","citation_count":68,"is_preprint":false},{"pmid":"17675299","id":"PMC_17675299","title":"Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol kinase subcellular localization.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17675299","citation_count":67,"is_preprint":false},{"pmid":"32947951","id":"PMC_32947951","title":"New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32947951","citation_count":66,"is_preprint":false},{"pmid":"11809841","id":"PMC_11809841","title":"Diacylglycerol kinase delta suppresses ER-to-Golgi traffic via its SAM and PH domains.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/11809841","citation_count":66,"is_preprint":false},{"pmid":"28918129","id":"PMC_28918129","title":"Where do substrates of diacylglycerol kinases come from? Diacylglycerol kinases utilize diacylglycerol species supplied from phosphatidylinositol turnover-independent pathways.","date":"2017","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/28918129","citation_count":66,"is_preprint":false},{"pmid":"12084710","id":"PMC_12084710","title":"Phorbol ester-regulated oligomerization of diacylglycerol kinase delta linked to its phosphorylation and translocation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12084710","citation_count":61,"is_preprint":false},{"pmid":"23209562","id":"PMC_23209562","title":"Wiki-pi: a web-server of annotated human protein-protein interactions to aid in discovery of protein function.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23209562","citation_count":57,"is_preprint":false},{"pmid":"28707095","id":"PMC_28707095","title":"Chronic administration of myristic acid improves hyperglycaemia in the Nagoya-Shibata-Yasuda mouse model of congenital type 2 diabetes.","date":"2017","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/28707095","citation_count":53,"is_preprint":false},{"pmid":"25112873","id":"PMC_25112873","title":"Diacylglycerol kinase δ phosphorylates phosphatidylcholine-specific phospholipase C-dependent, palmitic acid-containing diacylglycerol species in response to high glucose levels.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25112873","citation_count":52,"is_preprint":false},{"pmid":"11309392","id":"PMC_11309392","title":"Nuclear diacylglycerol kinase-theta is activated in response to alpha-thrombin.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11309392","citation_count":51,"is_preprint":false},{"pmid":"22761715","id":"PMC_22761715","title":"Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22761715","citation_count":44,"is_preprint":false},{"pmid":"17357084","id":"PMC_17357084","title":"Disruption of diacylglycerol kinase delta (DGKD) associated with seizures in humans and mice.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17357084","citation_count":41,"is_preprint":false},{"pmid":"26530149","id":"PMC_26530149","title":"Diacylglycerol kinase-δ regulates AMPK signaling, lipid metabolism, and skeletal muscle energetics.","date":"2015","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26530149","citation_count":31,"is_preprint":false},{"pmid":"17880279","id":"PMC_17880279","title":"Regulation of clathrin-dependent endocytosis by diacylglycerol kinase delta: importance of kinase activity and binding to AP2alpha.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17880279","citation_count":30,"is_preprint":false},{"pmid":"25362140","id":"PMC_25362140","title":"Expression and localization of type II diacylglycerol kinase isozymes δ and η in the developing mouse brain.","date":"2014","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/25362140","citation_count":29,"is_preprint":false},{"pmid":"27206979","id":"PMC_27206979","title":"Myristic Acid Enhances Diacylglycerol Kinase δ-Dependent Glucose Uptake in Myotubes.","date":"2016","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/27206979","citation_count":26,"is_preprint":false},{"pmid":"32134507","id":"PMC_32134507","title":"1-Stearoyl-2-docosahexaenoyl-phosphatidic acid interacts with and activates Praja-1, the E3 ubiquitin ligase acting on the serotonin transporter in the brain.","date":"2020","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/32134507","citation_count":26,"is_preprint":false},{"pmid":"20857926","id":"PMC_20857926","title":"Zinc binding drives sheet formation by the SAM domain of diacylglycerol kinase δ.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20857926","citation_count":25,"is_preprint":false},{"pmid":"31980461","id":"PMC_31980461","title":"Diacylglycerol kinase δ and sphingomyelin synthase-related protein functionally interact via their sterile α motif domains.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31980461","citation_count":24,"is_preprint":false},{"pmid":"35121028","id":"PMC_35121028","title":"DNA methylation differences between male and female gonads of the oyster reveal the role of epigenetics in sex determination.","date":"2022","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/35121028","citation_count":24,"is_preprint":false},{"pmid":"33621517","id":"PMC_33621517","title":"Sphingomyelin synthase-related protein generates diacylglycerol via the hydrolysis of glycerophospholipids in the absence of ceramide.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33621517","citation_count":24,"is_preprint":false},{"pmid":"27423518","id":"PMC_27423518","title":"Behavioral and pharmacological phenotypes of brain-specific diacylglycerol kinase δ-knockout mice.","date":"2016","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/27423518","citation_count":23,"is_preprint":false},{"pmid":"28955976","id":"PMC_28955976","title":"Diacylglycerol kinase ζ generates dipalmitoyl-phosphatidic acid species during neuroblastoma cell differentiation.","date":"2016","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/28955976","citation_count":23,"is_preprint":false},{"pmid":"21477072","id":"PMC_21477072","title":"Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cells.","date":"2011","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/21477072","citation_count":22,"is_preprint":false},{"pmid":"33464721","id":"PMC_33464721","title":"Increasing skeletal muscle carnitine content in older individuals increases whole-body fat oxidation during moderate-intensity exercise.","date":"2021","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/33464721","citation_count":22,"is_preprint":false},{"pmid":"23184957","id":"PMC_23184957","title":"Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23184957","citation_count":21,"is_preprint":false},{"pmid":"20064931","id":"PMC_20064931","title":"Diacylglycerol kinase delta and protein kinase C(alpha) modulate epidermal growth factor receptor abundance and degradation through ubiquitin-specific protease 8.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20064931","citation_count":21,"is_preprint":false},{"pmid":"31010675","id":"PMC_31010675","title":"Creatine kinase muscle type specifically interacts with saturated fatty acid- and/or monounsaturated fatty acid-containing phosphatidic acids.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31010675","citation_count":21,"is_preprint":false},{"pmid":"31891772","id":"PMC_31891772","title":"Diacylglycerol kinase δ destabilizes serotonin transporter protein through the ubiquitin-proteasome system.","date":"2019","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/31891772","citation_count":20,"is_preprint":false},{"pmid":"24090246","id":"PMC_24090246","title":"Diacylglycerol kinase delta promotes lipogenesis.","date":"2013","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24090246","citation_count":19,"is_preprint":false},{"pmid":"25847921","id":"PMC_25847921","title":"mRNA expression of diacylglycerol kinase isoforms in insulin-sensitive tissues: effects of obesity and insulin resistance.","date":"2015","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/25847921","citation_count":19,"is_preprint":false},{"pmid":"37469802","id":"PMC_37469802","title":"Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood ETV6::RUNX1+ and High Hyperdiploid Acute Lymphoblastic Leukemia.","date":"2023","source":"HemaSphere","url":"https://pubmed.ncbi.nlm.nih.gov/37469802","citation_count":18,"is_preprint":false},{"pmid":"28120887","id":"PMC_28120887","title":"ER residency of the ceramide phosphoethanolamine synthase SMSr relies on homotypic oligomerization mediated by its SAM domain.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28120887","citation_count":18,"is_preprint":false},{"pmid":"24852321","id":"PMC_24852321","title":"Regulation of diacylglycerol kinase δ2 expression in C2C12 skeletal muscle cells by free fatty acids.","date":"2014","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/24852321","citation_count":18,"is_preprint":false},{"pmid":"22974639","id":"PMC_22974639","title":"Diacylglycerol kinase δ1 transiently translocates to the plasma membrane in response to high glucose.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22974639","citation_count":18,"is_preprint":false},{"pmid":"28706295","id":"PMC_28706295","title":"DGKδ triggers endoplasmic reticulum release of IFT88-containing vesicles destined for the assembly of primary cilia.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28706295","citation_count":16,"is_preprint":false},{"pmid":"19416640","id":"PMC_19416640","title":"Diacylglycerol kinase delta associates with receptor for activated C kinase 1, RACK1.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19416640","citation_count":15,"is_preprint":false},{"pmid":"23703849","id":"PMC_23703849","title":"Knockdown of diacylglycerol kinase delta inhibits adipocyte differentiation and alters lipid synthesis.","date":"2013","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23703849","citation_count":13,"is_preprint":false},{"pmid":"37932834","id":"PMC_37932834","title":"Inflammation and altered metabolism impede efficacy of functional electrical stimulation in critically ill patients.","date":"2023","source":"Critical care (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37932834","citation_count":13,"is_preprint":false},{"pmid":"40372791","id":"PMC_40372791","title":"Genetic variants predisposing to an increased risk of kidney stone disease.","date":"2025","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/40372791","citation_count":12,"is_preprint":false},{"pmid":"30980919","id":"PMC_30980919","title":"Myristic acid specifically stabilizes diacylglycerol kinase δ protein in C2C12 skeletal muscle cells.","date":"2019","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/30980919","citation_count":12,"is_preprint":false},{"pmid":"23940809","id":"PMC_23940809","title":"Clonal expansion analysis of transposon insertions by high-throughput sequencing identifies candidate cancer genes in a PiggyBac mutagenesis screen.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23940809","citation_count":12,"is_preprint":false},{"pmid":"25886283","id":"PMC_25886283","title":"Genome-wide association study of serum minerals levels in children of different ethnic background.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25886283","citation_count":12,"is_preprint":false},{"pmid":"38843995","id":"PMC_38843995","title":"Diacylglycerol kinase delta overexpression improves glucose clearance and protects against the development of obesity.","date":"2024","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/38843995","citation_count":11,"is_preprint":false},{"pmid":"29859210","id":"PMC_29859210","title":"Diacylglycerol kinase δ controls down-regulation of cyclin D1 for C2C12 myogenic differentiation.","date":"2018","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/29859210","citation_count":10,"is_preprint":false},{"pmid":"29486157","id":"PMC_29486157","title":"Abnormalities of the serotonergic system in diacylglycerol kinase δ-deficient mouse brain.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29486157","citation_count":10,"is_preprint":false},{"pmid":"28742439","id":"PMC_28742439","title":"DaMab-2: Anti-Human DGKα Monoclonal Antibody for Immunocytochemistry.","date":"2017","source":"Monoclonal antibodies in immunodiagnosis and immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/28742439","citation_count":10,"is_preprint":false},{"pmid":"35856166","id":"PMC_35856166","title":"Myristic acid selectively augments β-tubulin levels in C2C12 myotubes via diacylglycerol kinase δ.","date":"2022","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/35856166","citation_count":9,"is_preprint":false},{"pmid":"35406411","id":"PMC_35406411","title":"Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35406411","citation_count":9,"is_preprint":false},{"pmid":"25972035","id":"PMC_25972035","title":"Association of common variants in the calcium-sensing receptor gene with serum calcium levels in East Asians.","date":"2015","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25972035","citation_count":9,"is_preprint":false},{"pmid":"33774855","id":"PMC_33774855","title":"Diacylglycerol kinase δ functions as a proliferation suppressor in pancreatic β-cells.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/33774855","citation_count":8,"is_preprint":false},{"pmid":"10224565","id":"PMC_10224565","title":"Construction and sequence analysis of subtraction complementary DNA libraries from human preimplantation embryos.","date":"1999","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10224565","citation_count":7,"is_preprint":false},{"pmid":"39368888","id":"PMC_39368888","title":"Upstream and downstream pathways of diacylglycerol kinase : Novel phosphatidylinositol turnover-independent signal transduction pathways.","date":"2024","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/39368888","citation_count":7,"is_preprint":false},{"pmid":"37942667","id":"PMC_37942667","title":"Comparative analysis of PDZ-binding motifs in the diacylglycerol kinase family.","date":"2023","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/37942667","citation_count":7,"is_preprint":false},{"pmid":"38916734","id":"PMC_38916734","title":"Adiponectin mRNA Conjugated with Lipid Nanoparticles Specifically Targets the Pathogenesis of Type 2 Diabetes.","date":"2024","source":"Aging and disease","url":"https://pubmed.ncbi.nlm.nih.gov/38916734","citation_count":7,"is_preprint":false},{"pmid":"35472624","id":"PMC_35472624","title":"Hepatic glycerolipid metabolism is critical to the egg laying rate of Guangxi Ma chickens.","date":"2022","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/35472624","citation_count":7,"is_preprint":false},{"pmid":"39992810","id":"PMC_39992810","title":"Human PHOSPHO1 exhibits phosphatidylcholine- and phosphatidylethanolamine-phospholipase C activities and interacts with diacylglycerol kinase δ.","date":"2025","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/39992810","citation_count":5,"is_preprint":false},{"pmid":"31837836","id":"PMC_31837836","title":"d-Glycerate kinase deficiency in a neuropediatric patient.","date":"2019","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/31837836","citation_count":5,"is_preprint":false},{"pmid":"37509516","id":"PMC_37509516","title":"Role of Diacylglycerol Kinases in Acute Myeloid Leukemia.","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/37509516","citation_count":5,"is_preprint":false},{"pmid":"30715374","id":"PMC_30715374","title":"Screening of subtype-specific activators and inhibitors for diacylglycerol kinase.","date":"2019","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30715374","citation_count":5,"is_preprint":false},{"pmid":"33997319","id":"PMC_33997319","title":"Diacylglycerol kinase η colocalizes and interacts with apoptosis signal-regulating kinase 3 in response to osmotic shock.","date":"2021","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/33997319","citation_count":4,"is_preprint":false},{"pmid":"39603461","id":"PMC_39603461","title":"Ubiquitin-specific peptidase 11 selectively interacts with and deubiquitination-dependently stabilizes diacylglycerol kinase δ to maintain cellular glucose uptake.","date":"2024","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/39603461","citation_count":2,"is_preprint":false},{"pmid":"39781426","id":"PMC_39781426","title":"Diacylglycerol kinase δ is required for skeletal muscle development and regeneration.","date":"2024","source":"FASEB bioAdvances","url":"https://pubmed.ncbi.nlm.nih.gov/39781426","citation_count":2,"is_preprint":false},{"pmid":"39637364","id":"PMC_39637364","title":"IDENTIFICATION AND VERIFICATION OF FEATURE BIOMARKERS ASSOCIATED WITH CHOLINE METABOLISM IN SEPSIS-INDUCED CARDIOMYOPATHY.","date":"2024","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/39637364","citation_count":2,"is_preprint":false},{"pmid":"28377914","id":"PMC_28377914","title":"A Case of 22q11 Deletion Syndrome (22q11DS) with a Panayiotopoulos Epileptic Pattern: Are Additional Copy-Number Variations a Possible Second Hit in Modulating the 22q11DS Phenotype?","date":"2017","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/28377914","citation_count":2,"is_preprint":false},{"pmid":"22406787","id":"PMC_22406787","title":"Analysis of the genotype of diacylglycerol kinase delta single-nucleotide polymorphisms in Parkinson disease in the Han Chinese population.","date":"2012","source":"Neurology India","url":"https://pubmed.ncbi.nlm.nih.gov/22406787","citation_count":1,"is_preprint":false},{"pmid":"37121690","id":"PMC_37121690","title":"Development of Therapeutic Agents with a Novel Mechanism of Action Targeting Pancreatic β-Cells for Diabetes.","date":"2023","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/37121690","citation_count":1,"is_preprint":false},{"pmid":"41431653","id":"PMC_41431653","title":"Sex-specific circRNA-miRNA-mRNA networks in peripheral blood mononuclear cells of patients with idiopathic pulmonary arterial hypertension: a pilot study.","date":"2025","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41431653","citation_count":1,"is_preprint":false},{"pmid":"41080753","id":"PMC_41080753","title":"Saturated fatty acid- and/or monounsaturated fatty acid-containing-phosphatidic acids selectively interact with and activate phosphoglycerate mutase 1.","date":"2025","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/41080753","citation_count":1,"is_preprint":false},{"pmid":"40921406","id":"PMC_40921406","title":"Diacylglycerol kinase gene Dgkh deficiency disrupts testicular lipid balance in male mice without affecting fertility.","date":"2025","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/40921406","citation_count":0,"is_preprint":false},{"pmid":"32944659","id":"PMC_32944659","title":"Epitope mapping of an anti-diacylglycerol kinase delta monoclonal antibody DdMab-1.","date":"2020","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/32944659","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43078,"output_tokens":8243,"usd":0.12644,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18224,"output_tokens":6760,"usd":0.13006,"stage2_stop_reason":"end_turn"},"total_usd":0.2565,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"DGKδ was cloned and identified as a diacylglycerol kinase with lipid kinase activity (phosphorylates DAG to produce phosphatidic acid). It contains a pleckstrin homology (PH) domain, two cysteine-rich zinc finger-like C1 structures, a C-terminal SAM-like domain, and a long Glu/Ser-rich insertion. DGK activity was detected in the particulate fraction of COS-7 cells expressing transfected DGKδ cDNA. The enzyme activity was independent of phosphatidylserine (unlike previously cloned DGKs alpha, beta, gamma).\",\n      \"method\": \"cDNA cloning, heterologous expression in COS-7 cells, in vitro DGK activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct enzymatic activity assay in cells, structural characterization, foundational cloning paper replicated by many subsequent studies\",\n      \"pmids\": [\"8626538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Alternative splicing of the DGKD gene generates two isoforms: DGKδ1 (130 kDa) and DGKδ2 (135 kDa, with 52 N-terminal residues extended). DGKδ1 translocates from cytoplasm to plasma membrane via its PH domain in response to phorbol ester stimulation, whereas DGKδ2 remains cytoplasmic because the delta2-specific N-terminal sequence blocks phorbol ester-dependent translocation. The two isoforms form homo- and hetero-oligomers as shown by co-immunoprecipitation of differently tagged proteins.\",\n      \"method\": \"Alternative splicing analysis, phorbol ester stimulation assays, subcellular localization by imaging, co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, subcellular localization with functional consequence (translocation), multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"12200442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DGKδ suppresses anterograde ER-to-Golgi transport via its SAM domain (acting as ER-targeting motif) and PH domain. Low-level expression redistributed Golgi membrane markers to the ER, delayed VSV-G protein transport, and abolished COPII-coated structure formation (labeled with Sec13p) without affecting COPI structures. Kinase-dead DGKδ mutants were equally effective, indicating the catalytic activity is not required for this function. Both SAM and PH domains were required.\",\n      \"method\": \"Expression of wild-type and kinase-dead DGKδ in NIH3T3 cells, VSV-G transport assay, BFA washout assay, immunofluorescence, domain deletion analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — kinase-dead mutagenesis, domain deletion analysis, multiple orthogonal functional assays in a single rigorous study\",\n      \"pmids\": [\"11809841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DGKδ forms homo-oligomeric structures via its C-terminal SAM domain, forming dimers and tetramers. Phorbol ester stimulation induces PKC-dependent phosphorylation of DGKδ, dissociation of oligomers, and translocation from cytoplasmic vesicles to the plasma membrane. DGKδ mutants lacking self-association localized constitutively at the plasma membrane even without phorbol ester. Staurosporine (PKC inhibitor) blocked all phorbol ester effects.\",\n      \"method\": \"Yeast two-hybrid, bacterial expression of SAM domain-MBP fusion, gel filtration, co-immunoprecipitation, phorbol ester stimulation, PKC inhibitor (staurosporine) treatment, subcellular localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reconstitution of SAM domain oligomers in vitro, co-IP in intact cells, mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"12084710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DGKδ deficiency in mice causes DAG accumulation, increased PKC-dependent threonine phosphorylation of EGFR, and reduced EGFR protein expression and activity. DGKδ-deficient pups showed open eyelids at birth and died shortly after birth, phenocopying EGFR knockout mice. Increased PKC autophosphorylation and enhanced phosphorylation of other PKC substrates was observed in DGKδ knockout cells, indicating DGKδ regulates EGFR by modulating PKC signaling.\",\n      \"method\": \"Gene knockout in mice, biochemical measurement of DAG, EGFR phosphorylation, PKC autophosphorylation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with defined molecular phenotype, multiple biochemical readouts, epistasis with PKC-EGFR pathway\",\n      \"pmids\": [\"17021016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DGKδ subcellular localization is regulated by glucose: in L6 myotubes overexpressing human insulin receptors, 25 mM glucose for 5 min transiently redistributed DGKδ (but not DGKα) from cytosol to plasma membrane fraction, reducing intracellular DAG and PKCα activity, and transactivating insulin receptor signaling and GLUT4 translocation. Antisense silencing of DGKδ (but not DGKα) prevented the effect of high glucose on PKCα activity, insulin receptor signaling, and glucose uptake.\",\n      \"method\": \"Antisense knockdown, subcellular fractionation, DGK activity assay, PKCα activity assay, insulin receptor signaling assay, GLUT4 translocation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-specific knockdown with defined signaling readouts, subcellular fractionation, multiple orthogonal methods\",\n      \"pmids\": [\"17675299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DGKδ (specifically DGKδ2) regulates clathrin-dependent endocytosis by binding to the AP2α subunit of the AP-2 complex via DXF-type motifs (F369DTFRIL and D746PF in the catalytic domain). DGKδ2 colocalized with clathrin-coated pits. Mutants lacking AP2α binding ability or kinase-negative mutants failed to rescue transferrin uptake inhibited by DGKδ siRNA knockdown, demonstrating that both the AP2α interaction and kinase activity are required for the endocytic function.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, domain mapping, kinase-dead mutagenesis, transferrin and EGF uptake assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, mutagenesis of binding motifs, kinase-dead mutant, functional rescue assay — multiple orthogonal methods\",\n      \"pmids\": [\"17880279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Reduced DGKδ expression and DGK activity were found in skeletal muscle from type 2 diabetic patients and diabetic animals. DGKδ haploinsufficiency in mice increased diacylglycerol content, reduced peripheral insulin sensitivity, insulin signaling, and glucose transport, and led to age-dependent obesity. Metabolic flexibility (transition between lipid and carbohydrate utilization) was impaired in DGKδ haploinsufficient mice. Correction of glycemia in diabetic animals restored DGKδ protein and DGK kinase activity.\",\n      \"method\": \"Human skeletal muscle biopsies, DGKδ haploinsufficient mouse model, DGK kinase activity assay, glucose transport assay, metabolic flexibility measurements\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — combined human and mouse genetic evidence, multiple metabolic readouts, kinase activity measurements; highly cited foundational study\",\n      \"pmids\": [\"18267070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DGKδ associates with RACK1 (receptor for activated C kinase 1) via WD40 repeats 5-7 of RACK1 interacting with aa 896-1097 of DGKδ. The interaction was selective for DGKδ over type I DGKs and was dynamically regulated by phorbol ester. DGKδ appeared to recruit RACK1 to clathrin-coated vesicles and co-localized with RACK1.\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation in COS-7 cells, subcellular localization, phorbol ester stimulation\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP with domain mapping, colocalization, single lab with two orthogonal approaches\",\n      \"pmids\": [\"19416640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DGKδ and PKCα regulate EGFR abundance through the deubiquitinase USP8. In DGKδ-deficient cells, ubiquitination of EGFR was enhanced, reducing steady-state EGFR levels and promoting ligand-induced EGFR degradation. This was not due to changes in the ubiquitinating apparatus but to reduced expression of USP8. PKCα, excessively active in DGKδ-deficient cells, inhibited Akt, which normally stabilizes USP8. Depletion of PKCα rescued USP8 levels and normalized EGFR degradation.\",\n      \"method\": \"DGKδ knockout cells, ubiquitination assay, USP8 expression analysis, PKCα depletion, Akt pathway analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO, epistasis analysis through PKCα-Akt-USP8 pathway, multiple biochemical readouts, mechanistic rescue experiments\",\n      \"pmids\": [\"20064931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The SAM domain of DGKδ forms helical polymers that are stabilized by zinc binding. Zinc drives organization of DGKδ-SAM into large sheets of polymers. A SAM domain mutant refractory to zinc binding diminishes cytoplasmic puncta formation, shows partially impaired regulation of transport to the plasma membrane, and lacks the ability to inhibit CopII-coated vesicle formation.\",\n      \"method\": \"Biochemical analysis of SAM domain, zinc binding studies, mutagenesis, cell-based localization assay, CopII vesicle formation assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro reconstitution of SAM polymer assembly, zinc-binding mutagenesis linked to functional cellular phenotypes, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"20857926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DGKδ deficiency reduces Akt phosphorylation downstream of three receptor tyrosine kinases. Mechanistically, PKCα (excessively active in DGKδ-deficient cells) promotes dephosphorylation of Akt through PHLPP2 (not PHLPP1). β-arrestin 1 acts as a scaffold for PHLPP2 and Akt1, providing mechanism specificity. Depletion of either PKCα or PHLPP2 rescued Akt phosphorylation in DGKδ-deficient cells. DGKδ deficiency reduced cell proliferation and migration and enhanced apoptosis.\",\n      \"method\": \"DGKδ-deficient cells, Akt phosphorylation assays, PKCα and PHLPP1/2 depletion, siRNA knockdown, cell proliferation and migration assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic depletion epistasis (PKCα vs PHLPP2 vs PHLPP1), isoform-specific rescue, multiple orthogonal functional readouts\",\n      \"pmids\": [\"23184957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DGKδ1 (but not DGKδ2 or type II DGKη1/2) specifically translocates from cytoplasm to plasma membrane within 5 min in response to high glucose in HEK293 and C2C12 cells. This translocation is regulated via the PI3-kinase pathway (blocked by LY294002 and GDC-0941). The PH and C1 domains are required for plasma membrane translocation, while the SAM domain negatively regulates it.\",\n      \"method\": \"Subcellular localization imaging, PI3-kinase inhibitors, domain deletion mutants, high glucose stimulation\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-selective translocation, pharmacological inhibition, domain mutagenesis, multiple cell lines\",\n      \"pmids\": [\"22974639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DGKδ2 preferentially phosphorylates palmitic acid (16:0)-containing diacylglycerol species (generating 30:0-, 32:0-, 34:0-PA and moderately 30:1-, 32:1-, 34:1-PA) in response to high glucose in C2C12 myoblasts. These DG species are supplied from the phosphatidylcholine-specific phospholipase C (PC-PLC) pathway (blocked by D609 inhibitor), not from the phosphatidylinositol turnover pathway. PC-PLC was co-immunoprecipitated with DGKδ2, indicating a physical interaction.\",\n      \"method\": \"LC/MS for PA species analysis, DGKδ-specific siRNA knockdown, DGKδ2 overexpression, PC-PLC inhibitor D609, co-immunoprecipitation, MS/MS analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — quantitative LC/MS substrate specificity, siRNA KD + overexpression, co-IP, pharmacological pathway blockade — multiple orthogonal methods\",\n      \"pmids\": [\"25112873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DGKδ deficiency impairs AMPK activation and signaling in isolated skeletal muscle, with concomitant impaired lipid oxidation and elevated incorporation of free fatty acids into triglycerides. DGKδ haploinsufficient mice showed reduced voluntary running activity and impaired work performance (altered force production and relaxation dynamics) during repeated contractions.\",\n      \"method\": \"DGKδ haploinsufficient mice, AMPK signaling assays, lipid oxidation measurements, voluntary running wheel, ex vivo muscle contraction force measurements\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mouse model, multiple biochemical and physiological readouts, single lab\",\n      \"pmids\": [\"26530149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Brain-specific DGKδ-knockout mice display OCD-like behaviors (compulsive checking, increased marble burying) alleviated by fluoxetine (SSRI). DGKδ deficiency increased the number of long axons/neurites in primary cortical neurons and knockdown neuroblastoma cells, whereas DGKδ overexpression decreased long axon/neurite number, indicating DGKδ regulates axon/neurite outgrowth.\",\n      \"method\": \"Brain-specific conditional DGKδ knockout mice, novel object recognition test, marble burying test, fluoxetine treatment, neurite outgrowth measurements in primary neurons and Neuro-2a cells\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with behavioral and cellular phenotypes, pharmacological rescue, gain-of-function overexpression corroboration\",\n      \"pmids\": [\"27423518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DGKδ is required for ER exit site function: it triggers the release of IFT88-containing vesicles from ER exit sites (ERES) for transport to the primary cilium. IFT88 interacts with DGKδ, and IFT88 associates with COPII-coated vesicles at ERES. DGKδ is required for supporting Sonic hedgehog (Shh) signaling both in vitro and in vivo.\",\n      \"method\": \"RNAi silencing and gene knockout, IFT88-DGKδ co-immunoprecipitation, COPII vesicle association assay, Shh signaling assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi + KO with cellular and in vivo Shh signaling phenotypes, co-IP for IFT88 interaction, single lab\",\n      \"pmids\": [\"28706295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DGKδ deficiency in the brain increases serotonin transporter (SERT) protein levels in the cerebral cortex, decreases tryptophan hydroxylase-2 expression, increases monoamine oxidase-A expression, and reduces serotonin (5-HT) levels. DGKδ interacted and co-localized with SERT in cortical neurons.\",\n      \"method\": \"Brain-specific DGKδ knockout mice, Western blot for SERT/TPH2/MAO-A, HPLC for 5-HT quantification, co-immunoprecipitation, colocalization imaging\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mouse with multiple serotonergic readouts, co-IP for SERT interaction, single lab\",\n      \"pmids\": [\"29486157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DGKδ controls down-regulation of cyclin D1 during C2C12 myogenic differentiation. DGKδ siRNA knockdown increased cyclin D1 and phospho-conventional/novel PKC (cnPKC) levels, and decreased myogenin expression and myosin heavy chain-positive cell number. These results indicate DGKδ regulates early myoblast differentiation by attenuating PKC signaling to control cyclin D1 down-regulation.\",\n      \"method\": \"siRNA knockdown, Western blot for cyclin D1/myogenin/myosin heavy chain/phospho-PKC, BrdU incorporation assay\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD with defined molecular and cellular phenotypes, mechanistic link to PKC signaling, single lab\",\n      \"pmids\": [\"29859210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DGKδ induces ubiquitination and proteasomal degradation of serotonin transporter (SERT) in a catalytic activity-dependent manner. Mechanistically, DGKδ interacts with MAGE-D1 adaptor protein and Praja-1 E3 ubiquitin-protein ligase, and enhances SERT ubiquitination through Praja-1. The catalytic subdomain-a and coiled-coil structure-containing region of DGKδ interacts with the C-terminal cytoplasmic region of SERT. Proteasome inhibitor MG-132 blocked DGKδ-dependent SERT degradation.\",\n      \"method\": \"Co-immunoprecipitation (DGKδ-SERT, DGKδ-MAGE-D1, DGKδ-Praja-1), domain mapping, catalytic mutants, ubiquitination assay, proteasome inhibitor treatment\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — catalytic activity-dependent mechanism, multiple co-IP interactions mapped, ubiquitination assay, pharmacological rescue, multiple orthogonal methods\",\n      \"pmids\": [\"31891772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DGKD knockdown impairs calcium-sensing receptor (CaSR) signal transduction in vitro, and this impairment is rectified by the calcimimetic cinacalcet. DGKD-associated genetic loci in kidney stone patients correlate with urinary calcium excretion, placing DGKD in the CaSR signaling pathway.\",\n      \"method\": \"siRNA knockdown of DGKD in CaSR-expressing cells, CaSR signaling assay, cinacalcet rescue\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with defined signaling readout and pharmacological rescue, supported by human genetic correlation; single lab in vitro validation\",\n      \"pmids\": [\"31729369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"1-stearoyl-2-docosahexaenoyl (18:0/22:6)-phosphatidic acid (PA), selectively generated by DGKδ from 18:0/22:6-DG, specifically binds to and enhances the activity of Praja-1 E3 ubiquitin ligase. In DGKδ-knockout mouse brain, 18:0/22:6-PA was decreased while 18:0/22:6-DG accumulated, confirming DGKδ selectively phosphorylates this DG species. Thus DGKδ generates a specific PA species that activates its downstream effector Praja-1 to degrade SERT.\",\n      \"method\": \"DGKδ-knockout mouse brain lipidomics (LC/MS), PA-Praja-1 binding assay, Praja-1 activity assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — KO mouse lipidomics identifying substrate specificity, in vitro protein-lipid binding and activity assay, mechanistic chain from DGKδ to PA species to Praja-1 activation\",\n      \"pmids\": [\"32134507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DGKδ interacts with sphingomyelin synthase-related protein (SMSr) through their respective SAM domains (SMSr-SAMD co-immunoprecipitates with DGKδ-SAMD; full-length interactions confirmed). SMSr overexpression significantly enhanced production of 16:0- or 16:1-containing PA species in DGKδ-overexpressing COS-7 cells. SMSr also enhanced DGKδ activity via their SAMDs in vitro, establishing SMSr as an upstream DG-providing enzyme for DGKδ.\",\n      \"method\": \"Co-immunoprecipitation (SAMD fragments and full-length), LC-MS/MS for PA species, in vitro DGK activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — SAM domain interaction mapped by co-IP, in vitro DGK activity assay, LC-MS/MS lipidomics — multiple orthogonal methods\",\n      \"pmids\": [\"31980461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"β-cell-specific DGKδ knockout mice showed lower blood glucose, higher plasma insulin, better glucose tolerance, increased small islets and Ki-67-positive islet cells, and elevated cyclin B1 expression. DGKδ knockdown in MIN6 β-cells increased BrdU incorporation and cyclin B1 expression. Streptozotocin-induced hyperglycemia and β-cell loss were alleviated in βDGKδ KO mice. DGKδ expression was detected in the nucleus of β-cells, establishing DGKδ as a suppressor of β-cell proliferation.\",\n      \"method\": \"β-cell-specific conditional DGKδ KO mice, Ki-67/cyclin B1 immunostaining, BrdU incorporation assay, streptozotocin model\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific KO, multiple proliferation readouts, KD confirmation in cell line, in vivo disease model rescue\",\n      \"pmids\": [\"33774855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP11 (ubiquitin-specific peptidase 11) specifically interacts with DGKδ protein complex and deubiquitinates DGKδ to stabilize it. The catalytic domain 1 region of USP11 and the C1 domains plus catalytic subdomain-a of DGKδ mediate their association. Inhibition of USP11 (by mitoxantrone or siRNA) markedly decreased DGKδ protein levels and increased DGKδ ubiquitination, impairing cellular glucose uptake.\",\n      \"method\": \"DGKδ-interactome analysis, co-immunoprecipitation, domain mapping, USP11 inhibitor (mitoxantrone), siRNA knockdown, ubiquitination assay, glucose uptake assay\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — interactome-based discovery, domain mapping, pharmacological + genetic inhibition, ubiquitination assay + rescue, functional glucose uptake readout\",\n      \"pmids\": [\"39603461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DGKδ is required for skeletal muscle development and regeneration. Myf5-promoter-driven conditional DGKδ knockout mice showed reduced body weight and skeletal muscle mass with reduced myofiber thickness. After cardiotoxin-induced muscle injury, DGKδ expression was highly upregulated, and DGKδ-deficient muscles showed reduced myofiber thickness, decreased embryonic myosin heavy chain and myogenin expression, and fewer newly formed centronucleated myofibers. DGKδ was expressed in myogenin-positive satellite cells around injured myofibers.\",\n      \"method\": \"Conditional DGKδ knockout (Myf5-Cre), cardiotoxin injury model, immunohistochemistry for muscle markers, Western blot\",\n      \"journal\": \"FASEB bioAdvances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO in two contexts (development and regeneration), multiple molecular markers, localization to satellite cells, single lab but comprehensive evidence\",\n      \"pmids\": [\"39781426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PHOSPHO1 (a cytosolic phosphatase) exhibits D609-sensitive PC-PLC and PE-PLC activities, generating saturated and/or monounsaturated fatty acid-containing DG species. DGKδ cosedimented and colocalized with PHOSPHO1, identifying PHOSPHO1 as a candidate upstream DG-supplying enzyme for DGKδ in a PI-turnover-independent pathway.\",\n      \"method\": \"In vitro phospholipase activity assay with purified PHOSPHO1, D609 inhibitor, PHOSPHO1 overexpression with DG quantification, co-sedimentation and colocalization assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro enzymatic activity assay, cellular DG quantification, colocalization/cosedimentation for interaction; single lab, single study\",\n      \"pmids\": [\"39992810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Reduced DGKδ expression and DGKD missense variants (identified via GWAS/Mendelian randomization) impaired CaSR signal transduction in vitro. This impairment was ameliorated by cinacalcet, a positive CaSR allosteric modulator. Drug target Mendelian randomization indicated reducing serum calcium via DGKD may reduce kidney stone disease relative risk by up to 90%.\",\n      \"method\": \"In vitro CaSR signaling assay with DGKD knockdown and missense variants, cinacalcet rescue, Mendelian randomization\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — variant-specific loss-of-function with defined signaling readout and pharmacological rescue, supported by GWAS colocalization; single lab in vitro validation\",\n      \"pmids\": [\"40372791\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DGKδ is a lipid kinase that phosphorylates diacylglycerol (DAG) to produce phosphatidic acid (PA), preferentially utilizing saturated/monounsaturated FA-containing DG species (via PC-PLC/SMSr/PHOSPHO1 pathways) and 18:0/22:6-DG (for brain SERT regulation); it is regulated by PKC-dependent oligomerization/translocation via its SAM and PH domains, stabilized by USP11-mediated deubiquitination, and acts in multiple signaling nodes including terminating PKC-EGFR signaling, modulating CaSR signal transduction, promoting clathrin-dependent endocytosis through AP2α binding, triggering ER-to-Golgi/primary cilia trafficking, suppressing β-cell proliferation, and generating specific PA species (notably 18:0/22:6-PA) that activate Praja-1 E3 ligase to degrade the serotonin transporter.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DGKD encodes diacylglycerol kinase δ (DGKδ), a lipid kinase that phosphorylates diacylglycerol (DAG) to phosphatidic acid (PA) and thereby attenuates DAG-driven protein kinase C (PKC) signaling across metabolic, proliferative, neuronal, and trafficking contexts [#0, #4]. The protein is built from a PH domain, two C1 zinc fingers, and a C-terminal SAM domain, and is expressed as two splice isoforms (DGKδ1 and DGKδ2) that differ in their N-terminus and in their capacity to translocate to the plasma membrane [#1]. SAM-domain–mediated, zinc-stabilized homo-oligomerization holds DGKδ in cytoplasmic vesicles; PKC-dependent phosphorylation downstream of phorbol ester or high glucose dissociates the oligomers and drives PH/C1-dependent translocation to the plasma membrane, where DGKδ consumes DAG [#3, #10, #12]. A central physiological output of this circuit is metabolic control: glucose-stimulated DGKδ relocalization lowers DAG and PKCα activity to enable insulin receptor signaling and GLUT4-mediated glucose uptake, and DGKδ deficiency in muscle causes DAG accumulation, insulin resistance, impaired AMPK and lipid oxidation, and obesity — a state mirrored in human diabetic skeletal muscle [#5, #7, #14]. DGKδ obtains its DAG substrate from a phosphatidylinositol-independent route, partnering with the DAG-supplying enzymes SMSr, PC-PLC, and PHOSPHO1 to generate saturated/monounsaturated PA species [#13, #22, #26]. Through its PKC-modulating activity DGKδ also stabilizes EGFR by preserving USP8 and limiting EGFR ubiquitination, and supports Akt signaling by restraining PKCα-driven, β-arrestin-1/PHLPP2-mediated Akt dephosphorylation, controlling proliferation, migration, and survival [#4, #9, #11]. Independently of its kinase activity, the SAM and PH domains target DGKδ to ER exit sites, where it regulates COPII-dependent ER-to-Golgi transport and releases IFT88-containing vesicles for primary cilium delivery to support Sonic hedgehog signaling; the kinase activity together with AP2α binding drives clathrin-dependent endocytosis [#2, #6, #16]. In the brain, DGKδ generates 18:0/22:6-PA that binds and activates the Praja-1 E3 ligase (via the MAGE-D1 adaptor) to ubiquitinate and degrade the serotonin transporter, and its loss produces OCD-like behavior corrected by SSRI [#15, #19, #21]. DGKδ further suppresses β-cell proliferation, is required for skeletal muscle development and regeneration, and is stabilized by USP11-mediated deubiquitination [#23, #24, #25]. Loss of DGKD function impairs calcium-sensing receptor (CaSR) signaling, linking DGKD variants to urinary calcium handling and kidney stone disease, with rescue by the calcimimetic cinacalcet [#20, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established DGKδ as a distinct DAG kinase, defining the catalytic activity and domain architecture that underlie all later mechanistic work.\",\n      \"evidence\": \"cDNA cloning and in vitro DGK activity assay of transfected enzyme in COS-7 cells\",\n      \"pmids\": [\"8626538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No physiological substrate or DAG species defined\", \"No cellular pathway context\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolved how DGKδ is held inactive and switched on, showing SAM-domain oligomerization and PKC-dependent phosphorylation gate PH-domain translocation to the plasma membrane, and that splice isoforms differ in this control.\",\n      \"evidence\": \"Alternative splicing analysis, phorbol ester stimulation, yeast two-hybrid, gel filtration, co-IP and localization in cells\",\n      \"pmids\": [\"12200442\", \"12084710\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PKC phosphorylation site not mapped\", \"Physiological trigger beyond phorbol ester unknown at this stage\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Revealed a kinase-independent trafficking role, showing the SAM and PH domains target DGKδ to the ER and suppress COPII-dependent ER-to-Golgi transport.\",\n      \"evidence\": \"Wild-type and kinase-dead expression in NIH3T3 cells with VSV-G transport, BFA washout, and domain deletion assays\",\n      \"pmids\": [\"11809841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cargo selectivity not defined\", \"Mechanism of COPII inhibition unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the core physiological logic — DGKδ degrades DAG to limit PKC, and its loss deranges PKC-EGFR signaling — with a lethal eyelid-open phenotype phenocopying EGFR knockout.\",\n      \"evidence\": \"Mouse gene knockout with DAG, EGFR phosphorylation, and PKC autophosphorylation measurements\",\n      \"pmids\": [\"17021016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific contributions not separated\", \"Downstream effectors of altered PKC not enumerated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected DGKδ to glucose homeostasis, showing glucose-triggered DGKδ membrane translocation lowers DAG/PKCα to enable insulin receptor signaling and GLUT4 translocation.\",\n      \"evidence\": \"Antisense knockdown, subcellular fractionation, and signaling/glucose-uptake assays in L6 myotubes\",\n      \"pmids\": [\"17675299\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal coupling glucose to translocation not defined here\", \"Isoform responsible not yet pinned down\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Linked DGKδ to human type 2 diabetes, demonstrating reduced muscle DGKδ in patients and that haploinsufficiency causes DAG accumulation, insulin resistance, and obesity.\",\n      \"evidence\": \"Human muscle biopsies and DGKδ haploinsufficient mice with kinase activity, glucose transport, and metabolic flexibility readouts\",\n      \"pmids\": [\"18267070\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causality vs consequence of reduced expression in patients not fully resolved\", \"Therapeutic targeting not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified a clathrin-endocytosis role requiring both AP2α binding via DXF motifs and kinase activity, mediated by the DGKδ2 isoform.\",\n      \"evidence\": \"Co-IP, domain/motif mapping, kinase-dead mutagenesis, and transferrin/EGF uptake rescue after siRNA knockdown\",\n      \"pmids\": [\"17880279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Local PA pool driving endocytosis not directly measured\", \"Cargo range beyond transferrin/EGF unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Added RACK1 as a phorbol-ester-regulated DGKδ partner recruited to clathrin-coated vesicles, integrating DGKδ with PKC scaffolding.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP with domain mapping, and colocalization in COS-7 cells\",\n      \"pmids\": [\"19416640\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of RACK1 recruitment not established\", \"No reciprocal validation in physiological cells\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Detailed how DGKδ controls EGFR abundance and Akt activity through PKCα, showing PKCα-driven loss of USP8 and PHLPP2/β-arrestin-1-mediated Akt dephosphorylation in DGKδ-deficient cells.\",\n      \"evidence\": \"DGKδ knockout cells with ubiquitination, USP8 expression, PKCα/PHLPP depletion, and Akt pathway analyses\",\n      \"pmids\": [\"20064931\", \"23184957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PA targets within these pathways not identified\", \"Tissue relevance of the PHLPP2 axis untested in vivo\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed zinc binding drives DGKδ-SAM into helical polymers required for cytoplasmic puncta, membrane translocation control, and COPII inhibition, mechanistically grounding the oligomerization switch.\",\n      \"evidence\": \"In vitro SAM polymer/zinc-binding studies with mutagenesis linked to cellular localization and COPII assays\",\n      \"pmids\": [\"20857926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of zinc-dependent assembly in vivo unknown\", \"Structural model of the full polymer not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined isoform-specific, PI3-kinase-dependent translocation, showing DGKδ1 responds to high glucose via PH/C1 domains while the SAM domain restrains translocation.\",\n      \"evidence\": \"Localization imaging with PI3K inhibitors and domain deletion mutants in HEK293/C2C12 cells\",\n      \"pmids\": [\"22974639\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream sensor of glucose not identified\", \"Link between PI3K and SAM-domain release unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established DGKδ substrate specificity and its DAG source, showing DGKδ2 phosphorylates 16:0-containing DAG supplied by PC-PLC, not PI turnover.\",\n      \"evidence\": \"LC/MS PA species analysis with siRNA/overexpression, PC-PLC inhibitor D609, and PC-PLC co-IP in C2C12 cells\",\n      \"pmids\": [\"25112873\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the PC-PLC enzyme not defined here\", \"Functional consequence of specific PA species not yet assigned\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended the trafficking role to ciliogenesis, showing DGKδ releases IFT88 vesicles from ER exit sites to support Sonic hedgehog signaling.\",\n      \"evidence\": \"RNAi/knockout, IFT88-DGKδ co-IP, COPII association, and Shh signaling assays in vitro and in vivo\",\n      \"pmids\": [\"28706295\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether kinase activity is required not established\", \"Mechanism of IFT88 vesicle release unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Uncovered a serotonergic function, showing brain DGKδ loss raises SERT and disrupts serotonin metabolism, producing OCD-like behavior rescued by SSRI, with DGKδ also restraining neurite outgrowth.\",\n      \"evidence\": \"Brain-specific conditional knockout with behavior, fluoxetine rescue, HPLC 5-HT, SERT co-IP, and neurite assays\",\n      \"pmids\": [\"27423518\", \"29486157\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of SERT regulation not yet defined at this stage\", \"Cell types responsible for behavior unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved the SERT mechanism, showing kinase-activity-dependent DGKδ recruits MAGE-D1 and Praja-1 to ubiquitinate and degrade SERT.\",\n      \"evidence\": \"Co-IP of DGKδ with SERT/MAGE-D1/Praja-1, domain mapping, catalytic mutants, ubiquitination assay, and MG-132 rescue\",\n      \"pmids\": [\"31891772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The PA species linking kinase activity to Praja-1 not yet identified here\", \"Stoichiometry of the complex unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed DGKD in the CaSR signaling pathway, linking its loss-of-function to impaired CaSR signaling and urinary calcium handling in kidney stone patients.\",\n      \"evidence\": \"siRNA knockdown in CaSR-expressing cells with signaling assay, cinacalcet rescue, and genetic locus correlation\",\n      \"pmids\": [\"31729369\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism coupling DGKδ to CaSR signaling not defined\", \"In vivo calcium phenotype not directly tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Closed the lipid-signaling loop for SERT, showing DGKδ selectively generates 18:0/22:6-PA that binds and activates Praja-1, and identifying SMSr as a SAM-domain partner supplying DAG.\",\n      \"evidence\": \"Knockout-brain lipidomics, PA-Praja-1 binding/activity assays, and SMSr-DGKδ SAM co-IP with LC-MS/MS and in vitro kinase assays\",\n      \"pmids\": [\"32134507\", \"31980461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single PA species achieves Praja-1 selectivity unresolved\", \"Generality of SMSr supply across tissues untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined DGKδ as a nuclear-localized suppressor of β-cell proliferation whose loss protects against streptozotocin-induced β-cell loss.\",\n      \"evidence\": \"β-cell-specific conditional knockout with Ki-67/cyclin B1/BrdU readouts and streptozotocin model\",\n      \"pmids\": [\"33774855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear substrate/target of DGKδ in β-cells unknown\", \"Relationship to PKC signaling in this context unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified post-translational stabilization of DGKδ, showing USP11 deubiquitinates DGKδ and is required to maintain its levels and downstream glucose uptake.\",\n      \"evidence\": \"Interactome analysis, co-IP with domain mapping, USP11 inhibition (mitoxantrone/siRNA), ubiquitination and glucose-uptake assays\",\n      \"pmids\": [\"39603461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase ubiquitinating DGKδ not identified\", \"Regulation of USP11-DGKδ engagement unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established DGKδ as required for skeletal muscle development and injury-induced regeneration, with upregulation in satellite cells after injury.\",\n      \"evidence\": \"Myf5-Cre conditional knockout, cardiotoxin injury model, and muscle-marker immunohistochemistry/Western blot\",\n      \"pmids\": [\"39781426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism in satellite cell differentiation not defined\", \"Lipid signaling basis of the regeneration defect unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Added PHOSPHO1 as a candidate PI-turnover-independent DAG supplier and strengthened the DGKD-CaSR-kidney stone link with variant-specific loss-of-function and Mendelian randomization.\",\n      \"evidence\": \"In vitro PHOSPHO1 phospholipase assays with D609 and DG quantification; CaSR signaling with DGKD variants, cinacalcet rescue, and Mendelian randomization\",\n      \"pmids\": [\"39992810\", \"40372791\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct demonstration that PHOSPHO1 feeds DGKδ in vivo lacking\", \"Causal mechanism of variants on CaSR signaling not fully defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DGKδ's distinct PA species are spatially channeled to specific effectors (Praja-1, AP2α-coupled endocytosis, CaSR, nuclear β-cell targets) across tissues, and what unifies its kinase-dependent versus kinase-independent functions, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of full-length DGKδ in its membrane-engaged state\", \"Effector selectivity for individual PA species mechanistically unexplained\", \"E3 ligase opposing USP11 stabilization unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 13, 21, 22]},\n      {\"term_id\": \"GO:0016301\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [6, 19]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 3, 12]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3, 5, 12]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 16]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [3, 6, 8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5, 11, 20]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5, 7, 14]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 6, 16]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [9, 19, 24]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [25, 16]}\n    ],\n    \"complexes\": [\"AP-2 clathrin adaptor complex\"],\n    \"partners\": [\"AP2A1\", \"RACK1\", \"SMSr/SAMD8\", \"PHOSPHO1\", \"IFT88\", \"SLC6A4/SERT\", \"PJA1/Praja-1\", \"USP11\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":10,"faith_total":10,"faith_pct":100.0}}